[ad_1]
PepsiCo’s stock headed toward a nine-month low in premarket action Thursday after the beverage and food giant reported a rare quarterly revenue miss, citing weakness in snack-food sales and the impacts of product recalls at Quaker Foods.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...